RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
25.55
-1.01 (-3.80%)
Mar 31, 2025, 2:25 PM EDT - Market open
RxSight Revenue
In the year 2024, RxSight had annual revenue of $139.93M with 57.09% growth. RxSight had revenue of $40.21M in the quarter ending December 31, 2024, with 40.71% growth.
Revenue (ttm)
$139.93M
Revenue Growth
+57.09%
P/S Ratio
7.38
Revenue / Employee
$280,978
Employees
498
Market Cap
1.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 139.93M | 50.85M | 57.09% |
Dec 31, 2023 | 89.08M | 40.07M | 81.77% |
Dec 31, 2022 | 49.01M | 26.41M | 116.90% |
Dec 31, 2021 | 22.59M | 7.92M | 53.92% |
Dec 31, 2020 | 14.68M | 12.44M | 554.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Dec 31, 2004 | Pro | Pro | Pro |
Dec 31, 2003 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RXST News
- 5 days ago - RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - RxSight, Inc. (RXST) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance - GlobeNewsWire
- 2 months ago - RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - GlobeNewsWire
- 3 months ago - RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye - Seeking Alpha
- 5 months ago - RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 - GlobeNewsWire